Edition:
United States

Insider Trading: Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

101.49USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$101.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
290,553
52-wk High
$112.83
52-wk Low
$90.21

All Insider Trades
Trading Date Name Title Type Shares Traded Price
7 Mar 2018

Cohen (Jon R)

Officer Sell 2,800 $104.77
7 Mar 2018

Cohen (Jon R)

Officer Sell 1,300 $104.77
7 Mar 2018

Cohen (Jon R)

Officer Sell 18,164 $104.09
7 Mar 2018

Cohen (Jon R)

Officer Sell 34,168 $104.09
7 Mar 2018

Cohen (Jon R)

Officer Buy 38,928 $66.51
7 Mar 2018

Cohen (Jon R)

Officer Sell 18,037 $104.09
7 Mar 2018

Cohen (Jon R)

Officer Sell 1,427 $104.76
7 Mar 2018

Cohen (Jon R)

Officer Sell 7,773 $104.77
4 Mar 2018

Davis James E

Officer Sell 5,122 $101.00
4 Mar 2018

Prevoznik (Michael E)

General Counsel Sell 4,128 $101.00
1 Mar 2018

Cohen (Jon R)

Officer Sell 5,393 $101.00
1 Mar 2018

Cohen (Jon R)

Officer Buy 10,949 $101.00
1 Mar 2018

Cunningham Everett

Officer Buy 10,949 $101.00
1 Mar 2018

Rusckowski (Stephen H)

Chief Executive Officer Sell 23,428 $101.00
1 Mar 2018

Guinan (Mark J)

Chief Financial Officer Buy 13,137 $101.00
1 Mar 2018

Prevoznik (Michael E)

General Counsel Sell 4,006 $101.00
1 Mar 2018

Prevoznik (Michael E)

General Counsel Buy 8,134 $101.00
1 Mar 2018

Rusckowski (Stephen H)

Chief Executive Officer Buy 43,789 $101.00
1 Mar 2018

Guinan (Mark J)

Chief Financial Officer Sell 6,471 $101.00
1 Mar 2018

Klug Robert A

Officer Buy 1,365 $101.00
1 Mar 2018

Cunningham Everett

Officer Sell 5,393 $101.00
1 Mar 2018

Klug Robert A

Officer Sell 429 $101.00
1 Mar 2018

Davis James E

Officer Buy 11,886 $101.00
1 Mar 2018

Davis James E

Officer Sell 6,764 $101.00
27 Feb 2018

Prevoznik (Michael E)

General Counsel Sell 496 $104.99

Institutional Holders

% Shares Owned: 91.50%
# of Holders: 870
Total Shares Held: 124,244,713
3 Mo. Net Change: 491,370
# New Positions: 9
# Closed Positions: 8
# Increased Positions: 54
# Reduced Positions: 53
# Net Buyers: 1

Officers & Directors

Name Age Since Current Position

Stephen Rusckowski

60 2017 Chairman of the Board, President, Chief Executive Officer

Mark Guinan

55 2013 Chief Financial Officer, Executive Vice President

James Davis

54 2017 Executive Vice President, General Diagnostics

Michael Prevoznik

55 2003 Senior Vice President, General Counsel

Jon Cohen

62 2013 Senior Vice President, Group Executive - Diagnostic Solutions

Everett Cunningham

50 2012 Senior Vice President - Commercial

Catherine Doherty

54 2017 Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing

Carrie Manner

42 2017 Senior Vice President - Advanced Diagnostics

Daniel Stanzione

71 2017 Lead Independent Director

Jenne Britell

74 2005 Independent Director

Vicky Gregg

62 2014 Independent Director

Jeffrey Leiden

61 2014 Independent Director

Timothy Main

60 2014 Independent Director

Gary Pfeiffer

67 2004 Independent Director

Timothy Ring

60 2011 Independent Director

Gail Wilensky

73 1997 Independent Director

Shawn Bevec

2016 Executive Director Investor Relations